Marcus had practiced his answer before anyone asked the question. By the time a colleague stopped him in the hallway after a staff meeting, “Man, you look different. What are you doing?” he had a smooth response ready: cleaner eating, better sleep, less drinking. All of it true. Just incomplete.
“I told myself it was private, which it is,” Marcus says now, several months into tirzepatide (a GLP-1 medicine). “But there’s a difference between keeping something private and hiding something because you’re ashamed of it.”
Marcus is one of two composite patients, drawn from years of clinical work with people using GLP-1 medicines, whose stories anchor this piece on shame and stigma during GLP-1 treatment. The second is Diane, a cardiac nurse who has spent her career telling patients that obesity is biological, not a character flaw, and who is still working out how to extend that same belief to herself.
Two Forms of Stigma
Researchers distinguish between two forms of stigma.1 Enacted stigma arrives from outside: the raised eyebrow, the offhand comment, the relative who suggests you’re taking the easy way out. Self-stigma is the critical inner voice that runs automatically even when no one else is around. Both forms are active throughout the GLP-1 journey. And they often show up more than once.
In clinical practice with GLP-1 medicines, four moments are influenced by stigma: (1) the decision to start treatment, (2) the social experience of using it, (3) the choice to continue long-term, and (least expected) (4) the moments when treatment is visibly succeeding.2 Marcus and Diane each lived through two of them.
1. The Gatekeeper: The Barrier to Starting
By the time Marcus seriously considered tirzepatide, he had already spent three months turning the decision over privately. He researched the way he approaches most things: mechanism first, evidence second. Intellectually, he was convinced.
What slowed him down was something he never mentioned to anyone, a moment catching his reflection in a mirrored gym wall during a student demonstration. The shame he felt from that brief moment paused him for months.
Like Marcus, most people arriving at a prescriber’s office for a GLP-1 medicine are not encountering weight stigma for the first time. They are arriving with years of it already absorbed.3 The intake process itself, the weigh-in, the BMI conversation, can subtly reactivate that history before any prescription is written.
This pathway also runs in a direction patients rarely see: the clinician’s side of the exam room. A provider’s own unexamined assumptions about who will “comply,” who has “really tried hard enough,” or who “deserves” the medicine invisibly shape the conversation, whether or not they’re spoken aloud.4
2. The Isolator: The Barrier to Social Support
Diane’s version was hidden inside and lasted longer.
“I know better,” she told her therapist early in treatment. “I literally teach this to my patients. I tell them it’s biology, not willpower, and I mean every word of it. But when it’s me, there’s a voice that says I should have been able to do this on my own.”
What makes this pathway distinct from the first is that the shame doesn’t block the decision to start; it shapes what happens after. This is where stigma does some of its most consequential damage.2 Research on disclosure consistently finds that the extremes carry the most risk: (a) total concealment isolates a person from the social support that improves outcomes, while (b) indiscriminate openness exposes them to the full range of other people’s unprocessed opinions. What tends to serve people best is something in between: deliberate, selective disclosure to a small number of people likely to respond with curiosity rather than judgment.
3. The Saboteur: The Barrier to Long-Term Commitment
Most people expect the “cheating” feeling to fade with time. For many, it does. Until it comes back.5
Eighteen months into treatment, Diane noticed her inner critic hadn’t disappeared so much as hibernated. It resurfaced after an offhand comment from a relative she rarely sees: “Do you really need to take that forever?” Nothing about the question was hostile. It still hurt.
The useful response here is one Diane uses often: If a patient came to her with this exact biological picture, would she tell them they were taking the easy way out? Her answer is no, immediately, unequivocally. The gap between that answer and how she sometimes still talks to herself is not evidence she’s failing at this. It’s evidence that self-stigma doesn’t resolve in one sitting. It must be responded to repeatedly and gradually replaced.
4. The Imposter: The Barrier to Internalizing Success
Return to the school hallway. Marcus had prepared for being asked about his weight loss. What he wasn’t ready for was how the question itself would feel: genuinely admiring, yet somehow still loaded.
This is the pathway that surprises people most, because it inverts the expectation that stigma is something you escape by succeeding. “You look amazing; what are you doing?” for example, carries an implicit comment on how you looked before. Even warm, well-meant attention can feel like exposure when the change becomes visible faster than the person inside it has caught up.6
For Marcus, this was stigma showing up at the exact moment the treatment was demonstrably working, dressed as a compliment. Understanding this in advance doesn’t make the moment painless. But it does change what the moment means: not evidence that something is wrong with how you’re handling this, but a predictable feature of a culture still catching up to what successful treatment actually looks like from the inside.
A Reframe for a Rewarding GLP-1 Journey
Most people brace for shame and stigma the way they’d brace for a single difficult conversation: something to get through once before the “real” journey begins. The four pathways above suggest something less tidy yet more useful to know in advance. Stigma isn’t a one-time visitor. It shows up at the start, during the middle, in the questions that resurface even years later, and sometimes precisely when things are outwardly going well. Each appearance can call for a different response, and expecting only one occurrence is part of why the second, third, or fourth can feel so disorienting when it arrives. The outcome is worth the work to get there.
